$6.44
N/A
Last update: Oct 2, 10:43 AM
COSCIENS BIOPHARMA INC by COSCIENS Biopharma Inc
CSCIFOTCQB
COSCIENS BIOPHARMA INC by COSCIENS Biopharma Inc (CSCIF) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | — | — | — | — |
| Actual | $-0.19 | $2.90 | $-0.69 | $-0.57 |
| Surprise | — | — | — | — |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $3.1M | $1.9M | $1.8M | $1.5M |
| Surprise | — | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | May 14, 2024 | $-4.74 | $-3.24 | -46.3 % |
| Q4 | Mar 27, 2024 | $-4.64 | $-3.88 | -19.6 % |
| Q3 | Nov 9, 2023 | $-3.40 | $-2.44 | -39.3 % |
| Q2 | Aug 9, 2023 | $-2.08 | $-3.48 | 40.2 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 13, 2024 | $2.30M | $1.10M | 109.1 % |
| Q1 | May 14, 2024 | $4.00K | $1.10M | -99.6 % |
| Q3 | Nov 9, 2023 | $3.00K | $2.30M | -99.9 % |
| Q2 | Aug 9, 2023 | $2.25M | $1.14M | 97.0 % |
